Application of stropharia rugoso-annulata polysaccharide in oxidation resistance, immune enhancement and intestinal flora regulation
By extracting and purifying polysaccharides from the oxobata, the problem of insufficient research on polysaccharides from the oxobatata is solved, and its multiple effects in antioxidant, immune enhancement and intestinal microbiota regulation are achieved, providing new animal nutrition Health care and veterinary medicine applications.
Patent Information
- Application Number
- CN202410861197.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-06-28
- Publication Date
- 2024-12-03
AI Technical Summary
In the prior art, there are few studies on polysaccharides of the bulbaceous caisson, and there is a lack of effective antioxidant, immune enhancement and intestinal microbiota regulation applications.
A novel polysaccharide with clear structure was extracted and purified from the large bulbaceous caisson. The polysaccharide with antioxidant, immune regulation and intestinal flora regulation effects were obtained by water alcohol precipitation and multi-step filtration and purification treatment.
Polysaccharides of the genus caisson significantly eliminate free radicals in in vitro and in vivo experiments, enhance cellular and humoral immunity, regulate intestinal flora, increase probiotic abundance, reduce pathogenic bacteria abundance, and have antioxidant, immune enhancement and intestinal Multiple effects of tract flora regulation.
Smart Images

Figure CN119055675A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of animal nutrition and health care and veterinary medicine, and relates to the application of Stropharia capillaris polysaccharide in anti-oxidation, immune enhancement and intestinal flora regulation. Background Art
[0002] The information disclosed in this background technology section is only intended to enhance the understanding of the overall background of the invention, and should not necessarily be regarded as an admission or any form of suggestion that the information constitutes the prior art already known to a person skilled in the art.
[0003] As the animal body grows and develops, the function of the immune system gradually improves, playing a role in resisting pathogen invasion. Immune system disorders reduce the resistance of animals to diseases. With the development of the breeding industry, the scale of intensive animal breeding is expanding. In order to maintain the economy and safety of production, feed additives are widely used. Currently, commonly used feed additives mainly contain vitamins, probiotics, trace elements, Chinese herbal medicines and extracts. Among them, plant polysaccharides such as astragalus polysaccharides and shiitake polysaccharides and fungal polysaccharides have clear immune enhancement effects, which can improve the disease resistance of animals and are welcomed by the majority of breeders. The intestine is considered to be the largest immune organ in the body, responsible for 70% of the body's immune function. Studies have shown that polysaccharides are immunogenic, and using polysaccharides as vaccine adjuvants can effectively activate intestinal immunity. Polysaccharides also further regulate intestinal immune responses by regulating the composition of intestinal flora.
[0004] Stropharia rugosoannulata Farl.ex Murrill, also known as red pine mushroom, ring-wrinkled stropharia, and Pseudo-black umbrella of F. philippinarum, is a fungus of the genus Stropharia in the family Strophariaceae. Stropharia is rich in nutrition, crisp and tender in taste, and has a strong umami flavor. It has the effects of improving immunity, relieving mental fatigue, helping digestion, and preventing coronary heart disease. However, there are still few studies on polysaccharides of Stropharia rugosoannulata in the prior art, so it is necessary to further explore and study it. Summary of the invention
[0005] In view of the shortcomings of the prior art, the present invention provides a polysaccharide of Stropharia rugosa and its application in anti-oxidation, immune enhancement and intestinal flora regulation. Specifically, the present invention purifies a novel polysaccharide with a clear structure from Stropharia rugosa, and further studies have found that it has multiple functions such as anti-oxidation, immune enhancement and intestinal flora regulation. Based on the above research results, the present invention is completed.
[0006] In order to achieve the above technical objectives, the technical solution adopted by the present invention is as follows:
[0007] The first aspect of the present invention provides the use of Stropharia officinalis polysaccharide in any one or more of the following:
[0008] (a) Anti-oxidation or preparation of anti-oxidation products;
[0009] (b) immunomodulation or preparation of immunomodulatory products;
[0010] (c) Regulating intestinal flora or preparing products for regulating intestinal flora.
[0011] The antioxidant activity is specifically manifested as scavenging free radicals DPPH and ABTS.
[0012] The immunomodulation can be immune enhancement; specifically, in in vitro experiments, it can promote the proliferation and differentiation of spleen lymphocytes and enhance cellular immunity; in in vivo experiments, cyclophosphamide (CTX) was used to induce an immunosuppression model in mice, and the results showed that Pleurotus ostreatus polysaccharides can improve cellular immunity, enhance humoral immunity and activate intestinal immunity in mice, thereby antagonizing immunosuppressants.
[0013] The intestinal flora regulation can specifically alleviate the intestinal flora disorder induced by immunosuppressants; specifically, it increases the diversity of the intestinal flora of immunosuppressed mice, reduces the abundance of pathogenic bacteria Helicobacter and increases the abundance of probiotics Lactobacillus.
[0014] The Stropharia capillaris polysaccharide is extracted from Stropharia capillaris by water extraction and alcohol precipitation.
[0015] The products include, but are not limited to, food and medicine.
[0016] The food may include food for human consumption and food for non-human animal consumption (such as pet food, feed, feed additives, etc.).
[0017] The drugs include drugs for human use and drugs for non-human animals (ie, veterinary drugs).
[0018] Meanwhile, the non-human animals include vertebrates, such as fish, amphibians, reptiles, birds and mammals, which are not specifically limited here.
[0019] The second aspect of the present invention provides a method for preparing Stropharia capillaris polysaccharide, the preparation method comprising:
[0020] S1, extracting the stropharia with alcohol to remove pigments and fat-soluble small molecules, thereby obtaining stropharia residue;
[0021] S2, drying the Stropharia officinalis residue obtained in step S1, adding water for hydrothermal extraction, filtering and collecting the supernatant;
[0022] S3, subjecting the supernatant obtained in step S2 to alcohol precipitation, and collecting the precipitate;
[0023] S4. After separation and purification of the precipitate in step S3, Stropharia capillaris polysaccharide is obtained.
[0024] In step S1, the specific method of the alcohol extraction includes: using ethanol (such as 95% ethanol) for heating and reflux treatment 2-4 times (preferably 2 times);
[0025] In step S2, the drying is natural drying in the shade, and the specific conditions for water-adding heating extraction include: the extraction temperature is controlled at 90-100°C (preferably 100°C, i.e. boiling extraction), the extraction time is 1-3 hours (preferably 2 hours), and the number of extractions is 1-4 times (preferably 3 times).
[0026] The mass ratio of the Stropharia officinalis residue to water is 1:5-15, preferably 1:10.
[0027] In step S3, the alcohol precipitation method includes: adding 75% ethanol to the supernatant to make the final concentration 60%, precipitating the polysaccharide with alcohol, and collecting the precipitate after standing (standing overnight);
[0028] Furthermore, the ethanol is removed from the precipitate, and the precipitate is freeze-dried (vacuum) to obtain the crude polysaccharide of Stropharia rugosa.
[0029] In step S4, the specific method of separation and purification includes adding Sevag reagent to remove protein, and column purification steps;
[0030] The specific method of column purification includes chromatographic purification using DEAE-agarose gel FF (DEAE Sepharose FF) ion exchange column chromatography and Chromdex 200PG gel filtration column.
[0031] Specifically, DEAE-Sepharose FF ion exchange column was used for elution according to different salt concentration solutions to obtain SRP-E1 (dH2O elution), SRP-E2 (0.2M NaCl elution), SRP-E3 (0.5M NaCl elution) and SRP-E4 (1.0M NaCl elution). Since the SRP-E1 component has the highest sugar content, it was purified using a Chromdex 200PG gel chromatography column. The elution curve found that there was a highly symmetrical elution peak between 150-185min, and the purified SRP, i.e., Stropharia polysaccharide, was obtained after collection.
[0032] More specifically, the crude polysaccharide sample was centrifuged at 8000 rpm for 10 min to remove the precipitate, and filtered with a 0.45 μm microporous filter membrane. The filtrate was loaded onto an equilibrated DEAE-agarose gel FF ion exchange chromatography column with a loading volume of 30% of the column volume. After all the sample solution entered the chromatography column, it was sequentially filtered according to different salt concentrations (dH2O, 0.2 M NaCl, 0.5 M NaCl, 1.0 M The elution was separated by elution with 2 times column volume for each concentration, the elution rate was 15 ml / min, and the fractions were collected by an automatic fraction collector. 100 tubes of each eluate gradient were collected, and 10 ml was collected in each tube. The anthrone-sulfuric acid method was used, and the polysaccharide content in the eluate was tracked and detected by an ELISA instrument at 630 nm. The number of tubes was used as the horizontal coordinate, and the absorbance was used as the vertical coordinate to obtain the polysaccharide elution curve, and the eluates of each tube with different elution peaks were collected respectively, and the ion exchange column chromatography was repeated for multiple times; the eluate components collected were concentrated under reduced pressure, dialyzed with a dialysis bag with a cutoff value of 3.5 KDa, and vacuum freeze-dried to obtain components of each group; the dH2O elution component (named SRP-E1) was taken as the sample for gel filtration column chromatography;
[0033] The gel filtration column chromatography method comprises: dissolving the SRP-E1 polysaccharide sample prepared by ion exchange column chromatography with dH2O, centrifuging for 10 minutes at 8000rpm to remove the precipitate, filtering with a 0.45μm microporous filter membrane, loading the filtrate onto a balanced Chromdex 200PG gel filtration column, the loading amount being 1% of the column volume, eluting and separating with water after all the sample liquid enters the chromatography column, the flow rate being 1.8ml / min, collecting the eluate with an automatic partial collector, collecting 4.5ml per tube, eluting 1 times the column volume, collecting by online detection with a differential detector, collecting the eluate in the same elution peak region with a higher peak height and better symmetry, repeating the loading of the gel filtration column chromatography for multiple times to enrich and purify the polysaccharide; specifically, collecting the elution components in the 150-185min region; combining and collecting the eluate components, decompressing and concentrating, and vacuum freeze-drying to obtain the Stropharia polysaccharide separated and purified by gel filtration column chromatography.
[0034] The third aspect of the present invention provides a product, wherein the product at least comprises the above-mentioned Stropharia capillaris polysaccharide.
[0035] Said products include, but are not limited to, food and medicine;
[0036] As mentioned above, the food may include food for human consumption and food for non-human animal consumption (such as pet food, feed, feed additives, etc.).
[0037] The drugs include drugs for human use and drugs for non-human animals (ie, veterinary drugs).
[0038] Meanwhile, the non-human animals include vertebrates, such as fish, amphibians, reptiles, birds and mammals, which are not specifically limited here.
[0039] The product has any one or more of the following effects:
[0040] (a) Antioxidant;
[0041] (b) immune regulation;
[0042] (c) Regulation of intestinal flora.
[0043] Beneficial technical effects of one or more of the above technical solutions:
[0044] (1) The above technical solution discloses the antioxidant effect of Pleurotus ostreatus polysaccharide. The Pleurotus ostreatus polysaccharide can scavenge free radicals DPPH and ABTS in in vitro experiments and has antioxidant function.
[0045] (2) The above technical scheme discloses the immunoenhancing effect of Pleurotus eryngii polysaccharide. The Pleurotus eryngii polysaccharide can promote the proliferation and differentiation of spleen lymphocytes and enhance cellular immunity in in vitro experiments. In in vivo experiments, cyclophosphamide (CTX) was used to induce an immunosuppressive model in mice. The results showed that Pleurotus eryngii polysaccharide can improve cellular immunity, enhance humoral immunity and activate intestinal immunity in mice, thereby antagonizing the effects of immunosuppressants.
[0046] (3) The above technical scheme discloses the intestinal flora regulating effect of Stropharia capitis polysaccharide. The Stropharia capitis polysaccharide significantly regulated the intestinal flora disorder induced by immunosuppressants in an in vivo experiment. Stropharia capitis polysaccharide increased the diversity of intestinal flora in immunosuppressed mice, reduced the abundance of pathogenic bacteria Helicobacter and increased the abundance of probiotics Lactobacillus.
[0047] (4) The above-mentioned technical solution for extracting polysaccharides from Pleurotus ostreatus is simple, low-cost, universal, and easy to scale up, thus having good economic and social benefits. BRIEF DESCRIPTION OF THE DRAWINGS
[0048] The accompanying drawings in the specification, which constitute a part of the present invention, are used to provide a further understanding of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute improper limitations on the present invention.
[0049] Figure 1 The results of separation and purification of SRP of the present invention are shown in Figure 1; wherein A is an ion exchange column chromatography elution separation diagram of SRP, B is a gel filtration column chromatography separation elution diagram of SRP, C is an HPGPC chromatogram of SRP, and D is an infrared spectrum diagram of SRP.
[0050] Figure 2is the nuclear magnetic resonance result of SPR of the present invention; wherein A is the 1 H-NMR spectrum, B is SRP 13 C-NMR, C is the DEPT-135 spectrum of SRP, D is the HSQC spectrum of SRP, E is the COSY spectrum of SRP, F is the HMBC spectrum of SRP, and G is the NOESY spectrum of SRP.
[0051] Figure 3 It is a schematic diagram of the specific structure of the SRP of the present invention.
[0052] Figure 4 The results of the SRP antioxidant test of the present invention are shown in Figure 2; wherein A is the result of the SRP scavenging experiment on ABTS, B is the result of the SRP scavenging experiment on DPPH, and C is the result of the SRP scavenging experiment on GSH.
[0053] Figure 5 It is the safe concentration of SRP for lymphocytes and dendritic cells of the present invention; wherein A is the safe concentration of SRP for lymphocytes, and B is the safe concentration of SRP for dendritic cells.
[0054] Figure 6 The changes in lymphocyte proliferation when SRP of the present invention cooperates with LPS or PHA stimulation; wherein A is the changes in lymphocyte proliferation when SRP cooperates with LPS stimulation, and B is the changes in lymphocyte proliferation when SRP cooperates with PHA stimulation.
[0055] Figure 7 The present invention shows the effect of SRP on the typing of mouse spleen lymphocytes.
[0056] Figure 8 This is the effect of the SRP of the present invention on the body weight of mice.
[0057] Fig. 9 This is the effect of the SRP of the present invention on the spleen index and thymus index of mice.
[0058] Fig.10 This is the effect of the SRP of the present invention on the histology of mouse immune organs.
[0059] Fig.11 The figure shows the effect of the SRP of the present invention on the levels of IL-2, IL-6 and IFN-γ in mouse serum; wherein A is the level of IL-2 in mouse serum, B is the level of IL-6 in mouse serum, and C is the level of IFN-γ in mouse serum.
[0060] Fig.12 This is the effect of the SRP of the present invention on the intestinal histology of mice.
[0061] Fig.13 This is the effect of the SRP of the present invention on the secretion level of sIgA in the intestine.
[0062] Fig.14 This is the effect of cyclophosphamide of the present invention on intestinal lymphocytes.
[0063] Fig.15 This is the effect of the SRP of the present invention on intestinal lymphocytes.
[0064] Fig.16 The figure shows the effect of the SRP of the present invention on the richness and uniformity of intestinal microorganisms; wherein A is the Chao1 index graph, B is the OUT index graph, C is the Shannon index graph, and D is the Simpson index graph.
[0065] Fig.17 This is the effect of SRP treatment of the present invention on intestinal microbial β diversity.
[0066] Fig.18 This is the difference in intestinal microbial abundance at the Top 10 phylum level of the present invention.
[0067] Fig.19 It is the difference in intestinal microbial abundance at the genus level of the Top 20 of the present invention; wherein, A is the analysis of intestinal flora composition at the genus level, B is the change of Helicobacter genus after the action of SRP, and C is the change of Helicobacter genus after the action of SRP. DETAILED DESCRIPTION
[0068] It should be noted that the following detailed descriptions are all illustrative and intended to provide further explanation of the present invention. Unless otherwise specified, all technical and scientific terms used herein have the same meanings as those commonly understood by those skilled in the art to which the present invention belongs.
[0069] It should be noted that the terms used herein are only for describing specific embodiments and are not intended to limit exemplary embodiments according to the present invention. As used herein, unless the context clearly indicates otherwise, the singular form is also intended to include the plural form. In addition, it should be understood that when the terms "comprising" and / or "including" are used in this specification, they indicate the presence of features, steps, operations, devices, components and / or combinations thereof. It should be understood that the scope of protection of the present invention is not limited to the specific embodiments described below; it should also be understood that the terms used in the embodiments of the present invention are intended to describe specific embodiments, rather than to limit the scope of protection of the present invention.
[0070] The present invention is further explained by the following examples, but they are not intended to limit the present invention. It should be understood that these examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention.
[0071] Embodiment 1:
[0072] This example is used for the separation, purification and structure determination of SRP:
[0073] 1 Experimental methods:
[0074] 1.1 Extraction of crude polysaccharide from Stropharia: 500 g of Stropharia was chopped and extracted twice with 95% ethanol (3000 mL) by heating and refluxing to remove the pigment and fat-soluble small molecule components. The residue was taken out and aired to dry. Pure water with a mass ratio of 1:10 to Stropharia was added each time for boiling and extraction. Each time, the mixture was filtered through four layers of gauze. The residue was extracted with pure water of equal mass. The extraction was performed three times in total. The extracts were combined, boiled and concentrated to 1000 mL at normal pressure, cooled, centrifuged, and the precipitate was discarded. The supernatant was mixed with 75% ethanol at a ratio of 1:4 (v:v) to make the final concentration of the solution 60%. The solution was allowed to stand overnight, centrifuged to obtain a precipitate, the ethanol was evaporated, and the solution was freeze-dried in vacuum. This is crude polysaccharide from Stropharia. The freeze-dried crude polysaccharide was completely dissolved in pure water to prepare a 100 mg / mL crude polysaccharide solution. Sevag reagent (chloroform: n-butanol = 4:1) was added for repeated shaking extraction. After standing and stratification, the protein was denatured and entered the organic solvent to achieve the separation of polysaccharide and protein. This was repeated 8 times to remove the protein. The water part was recovered by a rotary evaporator and freeze-dried to obtain the Stropharia proteoglycan SRPt.
[0075] 1.2 Ion exchange column chromatography:
[0076] 1.2.1 Pretreatment of ion exchange chromatography medium: Pour the DEAE sepharose FF gel suspension into a Buchner funnel, drain the liquid, and wash with about 3 times the volume of ultrapure water. Repeat the above operation several times until the filler has no alcohol taste. Transfer it to a beaker, add distilled water of one-half to one times the volume of the sedimented gel, and stir well for column loading.
[0077] 1.2.2 Column loading and balancing: Stir the pretreated DEAE sepharose FF gel suspension and slowly add it to the XK chromatography column. After complete sedimentation, connect the upper column head to the peristaltic pump, start the pump at a flow rate of 250 cm / h, and flush the column with ultrapure water until the gel surface is stable to complete the column loading.
[0078] 1.2.3 Loading and elution: The polysaccharide sample was dissolved in dH2O and centrifuged at 8000rpm for 10min to remove the precipitate. The sample was filtered with a 0.45μm microporous filter membrane and the filtrate was loaded onto an equilibrated ion exchange chromatography column. The loading amount was 30% of the column volume. After all the sample solution entered the chromatography column, it was eluted and separated according to different salt concentrations (dH2O, 0.2M NaCl, 0.5M NaCl, 1.0M NaCl). Each concentration was eluted with 2 times the column volume at a rate of 15ml / min. The fractions were collected by an automatic fraction collector. 100 tubes of each eluate were collected in a gradient, and 10ml was collected in each tube. The anthrone-sulfuric acid method was used and the polysaccharide content in the eluate was tracked and detected by an enzyme marker at 630nm. The polysaccharide elution curve was obtained with the number of tubes as the horizontal axis and the absorbance as the vertical axis. The eluates of each tube with different elution peaks were collected respectively and the ion exchange column chromatography was repeated several times. The eluate fractions collected were combined and concentrated under reduced pressure, dialyzed with a dialysis bag with a cutoff value of 3.5 KDa, and freeze-dried in vacuum to obtain components of each group.
[0079] 1.3 Gel filtration column chromatography
[0080] 1.3.1 Pretreatment of gel filtration chromatography medium: Pour the gel filtration chromatography medium Chromdex 200PG gel suspension into a Buchner funnel, drain the liquid, and wash with about 3 times the volume of ultrapure water. Repeat the above operation several times until the filler has no alcohol taste, transfer it to a beaker, add distilled water of one-half to one times the volume of the sedimented gel, and stir well for column loading.
[0081] 1.3.2 Column loading and balancing: Stir the pretreated gel filtration chromatography medium Chromdex 200PG gel suspension and slowly add it to the XK chromatography column. After complete sedimentation, connect the upper column head to the chromatography system and flush the column with ultrapure water at a flow rate of 30 cm / h until the gel surface is stable to complete the column loading.
[0082] 1.3.3 Loading and elution: The polysaccharide sample prepared by ion exchange column chromatography was dissolved in dH2O, centrifuged at 8000rpm for 10min, the precipitate was removed, and filtered with a 0.45μm microporous filter membrane. The filtrate was loaded onto the equilibrated gel filtration chromatography, and the loading amount was 1% of the column volume. After the sample liquid entered the chromatography column, it was eluted and separated with ultrapure water at a flow rate of 1.8ml / min. The eluate was collected by an automatic partial collector, 4.5ml was collected in each tube, and 1 column volume was eluted. The eluate with a higher peak height and better symmetry in the same elution peak area was collected, and the gel filtration column chromatography was repeated several times to enrich the purified polysaccharide. The eluate components collected were combined, concentrated under reduced pressure, and freeze-dried in vacuum to obtain the polysaccharide separated and purified by gel filtration column chromatography.
[0083] 1.4 Monosaccharide composition and proportion
[0084] 1.4.1 Preparation of test samples: Accurately weigh 5 mg of each of rhamnose, arabinose, glucose, galactose, xylose, mannose, galacturonic acid, glucuronic acid, glucosamine hydrochloride, and galactosamine hydrochloride standards, and 10 mg of fucose standard, dissolve in ultrapure water to 10 mL, shake thoroughly to dissolve, as the standard mother solution, and then dilute to the concentration of monosaccharide standards, the gradient is shown in Table 1. Weigh 5 mg of SRP, accurately weigh, dissolve in 1 mL of 2M TFA acid solution, hydrolyze at 121 ° C for 2 hours. After the hydrolysis is completed, blow dry with nitrogen, wash the residue with 3 mL of methanol and blow dry again, repeat 2-3 times. Finally, add 5 mL of ultrapure water to dissolve it, transfer it to a clean chromatographic bottle and wait for detection.
[0085] Table 1 Monosaccharide standard mixed standard gradient concentration information
[0086]
[0087] 1.4.2 PMP derivatization: 0.2 mL of monosaccharide standard solution or polysaccharide hydrolyzate was measured and placed in a stoppered conical bottom centrifuge tube, and 0.2 mL of 0.5 mol / L sodium hydroxide solution and 0.5 mL of 0.5 mol / L PMP methanol solution were added, vortexed and mixed, and reacted in a 70°C water bath for 1 h. After the reaction was completed, 0.5 mol / L hydrochloric acid was added dropwise to the reactant, and the pH value of the solution was adjusted to neutral. Then 1 mL of chloroform was added, and the excess PMP was extracted by vortexing, and the chloroform layer was discarded. Repeat the extraction 3 times, and 0.3 mL of the water layer was taken and fixed to 1 mL with water.
[0088] 1.4.3 Chromatographic conditions Thermo U3000 liquid chromatography system was used to determine the content of the derivatized products of the complete acid hydrolysis products of standard monosaccharides and polysaccharides. ZORBAX EclipseXDB-C18 was selected as the detection column, acetonitrile was selected as the mobile phase, and a mixed solvent of phosphate buffer (12 g / L potassium dihydrogen phosphate, 2 M NaOH adjusted to pH = 6.8) and acetonitrile was used as the elution solvent. Isocratic elution was performed. The elution conditions were: the volume ratio of acetonitrile to phosphate buffer was 17:83 (v:v), the flow rate was 0.8 mL / min, the column temperature was 30 °C, the detection wavelength was 250 nm, and the injection volume was 10 μL.
[0089] 1.5 Molecular weight determination:
[0090] 1.5.1 Establishment of molecular weight calibration curve: Weigh dextran standards of different molecular weights (molecular weight 1000, 5000, 12000, 25000, 50000, 80000, 150000, 270000, 410000, 670000 series analytical standards), add 0.05M NaCl solution to prepare 5mg / ml dextran standard solution, filter with 0.22μm microporous filter membrane for later use, adopt HPGPC method, use high performance gel permeation chromatography tandem columns for detection, use the logarithm of the relative molecular mass of the standard as the ordinate, and use the retention time of the corresponding chromatographic peak as the abscissa for linear regression to obtain the calibration curve.
[0091] 1.5.2 Preparation of test sample solution: Weigh the purified polysaccharide sample, add 0.05M NaCl solution to the sample to prepare a 5mg / ml test sample solution, take the supernatant and filter it with a 0.22μm microporous filter membrane, then transfer the sample to a 2ml injection bottle for later use.
[0092] 1.5.3 Chromatographic method: HPGPC method was adopted, using a high performance liquid chromatograph equipped with a differential detector, polymer-based water-soluble SEC (GFC) chromatographic columns OHpak SB-803HQ, Ohpak SB-804HQ, Ohpak SB-805HQ (8×300mm) in series for detection, 0.05M NaCl solution as the mobile phase, a flow rate of 0.65ml / min, a column temperature of 40℃, and an injection volume of 30μl.
[0093] 1.6 Structure identification
[0094] 1.6.1 Infrared detection of Stropharia rugosa polysaccharides
[0095] 2 mg of SRP was weighed and placed in an agate mortar, and 200 mg of KBr powder was added, ground evenly, pressed into tablets, and placed on a NICOLETiS50R Fourier transform infrared microscope (Thermo Scientific) for infrared scanning of the sample, and the result graph was recorded.
[0096] 1.6.2 Methylation experiment of Stropharia rugosa polysaccharide
[0097] Weigh 3 mg of purified SRP into a 10 mL centrifuge tube, dissolve it with 500 μL DMSO, add 1 mg sodium hydroxide, incubate for 30 min, then add 50 μL iodomethane to react for 1 h, then add 1 mL water and 2 mL dichloromethane, shake thoroughly, centrifuge, discard the lower aqueous phase, and wash three times. Take the lower organic phase, evaporate to dryness in a water bath, add 100 μL 2M TFA to the residue, heat at 121 ° C for 90 min, and completely hydrolyze the fully methylated derivatives of SRP into monosaccharide derivatives. The hydrolyzate is then placed in a water bath and TFA is evaporated at 30 ° C. The residue was added with 50 μL 2M ammonia water and 50 μL 1M NaBD4, mixed and reacted at room temperature for 2.5 h, 20 μL acetic acid was added to terminate the reaction, the sample was blown dry with nitrogen, and then washed twice with 250 μL methanol. After drying with nitrogen, 250 μL acetic anhydride was added, mixed, reacted at 100°C for 2.5 h, 1 mL of purified water was added and allowed to stand for 10 min, then 500 μL of dichloromethane was added, mixed, centrifuged and the aqueous phase was discarded, the washing was repeated three times, and the lower dichloromethane solution was finally aspirated, and the content of methylated products was detected using 7890A-5977B gas spectrometer (Agilent 7890A; Agilent Technologies, USA).
[0098] 1.6.3 Nuclear Magnetic Resonance Detection of Stropharia rugosa Polysaccharides
[0099] Weigh a certain amount of SRP dried to constant weight, dissolve it in 0.5 mL of D2O, and add TMSP as an internal standard. Use a 600 MHz Bruker NMR spectrometer to measure the one-dimensional NMR spectra of SRP, 1H-NMR, 13C-NMR, DEPT-135, and the two-dimensional NMR spectra, 1H-1H COSY, HSQC, HMBC, and NOESY. Calibration: HDO hydrogen δH = δ4.70 ppm, TMSP methyl carbon δC = δ-1.80 ppm.
[0100] 2 Experimental results
[0101] like Figure 1 As shown in A, the crude polysaccharide sample was separated by an ion adsorption column to obtain four components, among which SRP-E1 with the highest sugar content was subsequently purified by a gel filtration column. Its elution curve is shown in Figure 1 As shown in B. The elution peak fractions at 150-185 min were collected and freeze-dried to obtain SRP. Figure 1 As shown in C, SRP was detected by HPGPC method, and the results showed that a single symmetrical peak appeared between the retention time of 38-44min, indicating that SRP had high purity and its chemical structure could be further analyzed. Substituting its retention time into the regression equation obtained by the standard product, its molecular weight was 9490Da. Figure 1D is the FT-IR test result of SRP, which shows that sample SRP is a neutral polysaccharide containing more pyran rings. Figure 2 is the NMR spectrum of SRP. The structure of SRP is as follows Figure 3 The monosaccharide composition and ratio results are shown in Table 2.
[0102] Table 2 Monosaccharide composition and ratio of polysaccharide SRP
[0103]
[0104] The purified Stropharia rugosa polysaccharide is the SRP (SFP) described in the present invention.
[0105] Example 2
[0106] This example is used to determine the antioxidant activity of SRP in Example 1:
[0107] 1 Experimental methods
[0108] 1.1 Drugs and materials
[0109] Stropharia capillaris polysaccharide, ABTS free radical scavenging detection kit, DPPH free radical scavenging detection kit, reduced GSH content detection kit, vitamin C.
[0110] 1.2 Detection Method
[0111] Perform the test according to the method provided by the kit supplier.
[0112] 2 Results
[0113] like Figure 4 As shown, based on the ABTS free radical scavenging rate (A), DPPH free radical scavenging rate (B) and GSH content (C), it can be seen that SRP has antioxidant activity.
[0114] Example 3
[0115] This example is used to determine the in vitro immunoreactivity of SRP in Example 1:
[0116] 1 Experimental methods
[0117] 1.1 Drugs and materials
[0118] Stropharia capillaris polysaccharide, cyclophosphamide, LPS, PHA, DMEM culture medium, cck-8, anti-Mouse CD3-FITC, anti-Mouse CD4-PE, anti-Mouse CD8-APC, ELISA kit, etc.
[0119] 1.2 Collection of splenic lymphocytes and dendritic precursor cells
[0120] Five healthy four-week-old ICR mice were selected and killed by cervical dislocation. The whole body was immersed in 75% alcohol for 5 minutes for disinfection. After draining the remaining ethanol, the mice were placed in a clean bench. The abdominal cavity was cut open aseptically, and the mouse spleen was removed. It was placed in a culture dish containing PBS solution and washed twice with PBS solution. The spleen was removed and the remaining tissue around the spleen was carefully peeled off with forceps and a cell needle. The cell sieve was moistened with PBS, and the spleen was placed on a 200-mesh cell sieve. The spleen was cut into pieces with ophthalmic scissors and gently ground with a grinding rod. While grinding, the cell sieve was carefully rinsed with PBS and filtered. The filtration was repeated until only white transparent fibrous tissue was left in the cell sieve. The filtered cells were collected in a sterile culture dish. Transfer the collected cells to a 15 mL centrifuge tube, add PBS to a volume of 15 mL, centrifuge at 1500 r / min for 10 min, remove the supernatant, add red blood cell lysis buffer to the remaining cells, blow and lyse for 5 min, centrifuge (under the same conditions), discard the supernatant, wash the remaining cells twice with PBS, centrifuge, take the cells and set aside.
[0121] Five healthy four-week-old Balb / c mice were selected, killed by cervical dislocation, and placed in 75% alcohol for 5 minutes for disinfection. After draining the remaining ethanol, the femur and tibia of the mouse were aseptically removed in a clean bench, the muscles, fascia and tendons attached to the bones were stripped, and then sterile gauze was used to repeatedly rub to remove various tissues attached to the bones. Then the epiphysis at both ends of the tibia and femur was cut off, and sterile PBS was injected into the bone marrow cavity of the femur and tibia with a 2.5mL syringe to repeatedly rinse several times until the bone marrow cavity turned white. All the flushing fluid was collected and transferred to a centrifuge tube and centrifuged at 1500rpm for 10min. After centrifugation, the supernatant was discarded, and red blood cell lysis solution was added. The cells were lysed by blowing for 5min, placed in a centrifuge and centrifuged at 1500rmp / min for 10min, the supernatant was removed, 10mL PBS was added, and centrifugation and washing were performed twice under the same conditions to obtain mouse bone marrow-derived dendritic precursor cells.
[0122] 1.3 CCK8 method to determine the safe concentration of SRP for cells
[0123] Take SRP, prepare a solution with a concentration of 2000μg / ml, and dilute it to 1.953123μg / ml. Use complete culture medium to adjust the mouse cells to a cell concentration of 2.5103 / mL, add them to a 96-well cell culture plate, add 90L to each well, and then add 100L of each concentration of Stropharia cap polysaccharide to each well. Set 4 wells for each group, and then place them in a cell culture incubator at 37°C and 5% CO2 for 44h. After 44h, add CCK8 solution, 10L per well, continue to culture for 4 hours, and then use an enzyme reader to measure the absorbance at 570nm and 450nm. The in vitro safe concentration of SRP is determined when the absorbance is not significantly less than that of the blank group.
[0124] 1.4 Effect of SRP on the typing of mouse spleen lymphocytes
[0125] SRP was prepared into solutions with concentrations of 125μg / mL, 62.5μg / mL and 31.25μg / mL using complete culture medium, corresponding to the three concentration groups of SRP-H, SRP-M and SRP-L, respectively. The mouse spleen lymphocytes were adjusted to the concentration and laid in a 24-well plate, and then three concentrations of SRP solution were added. At the same time, a blank group and a background cell group were set up, and four parallel wells were set up in each group. The cell plate was placed in a cell culture incubator and cultured for 48h. The cells cultured on the cell plate were collected, and the cells were stained with mouse CD3-FITC antibody, mouse CD4-PE antibody and mouse CD8-APC antibody. The lymphocyte typing was detected by flow cytometry. The staining method is as follows:
[0126] Add 1 mL of pre-cooled PBS to the collected cells, vortex for 15 seconds, centrifuge at 2500 rpm for 15 minutes, collect the cells, and repeat the rinse twice. Add 1 mL of pre-cooled PBS solution to each tube, and then add 1 μL of CD3-APC, CD4-PE and CD8-FITC antibodies. For the cells in the blank control group, add 1 mL of PBS solution without dye. Vortex for 15 seconds and incubate in a 4°C refrigerator away from light for 30 minutes.
[0127] 2 Experimental results
[0128] 2.1 Effect of SRP on the safe concentration of cells
[0129] like Figure 5 As shown, the maximum safe concentrations of SRP for lymphocytes and dendritic cells are 125 μg / ml and 250 μg / ml, respectively.
[0130] 2.2 Effect of C SRP on cell proliferation rate
[0131] like Figure 6 As shown, at 62.5 μg / ml and 31.25 μg / ml, SRP synergized with LPS to promote the proliferation of spleen lymphocytes. At 62.5 μg / ml, 31.25 μg / ml and 125 μg / ml, SRP synergized with PHA to promote the proliferation of spleen lymphocytes.
[0132] 2.3 Effect of SRP on the typing of mouse spleen lymphocytes
[0133] like Figure 7 As shown, SRP can increase the percentage of CD4 and CD8 lymphocytes.
[0134] Example 4
[0135] This example is used to determine the in vivo immune enhancement effect of SRP in Example 1:
[0136] 1 Experimental methods
[0137] 1.1 Drugs and materials
[0138] Stropharia capillaris polysaccharide, cyclophosphamide, anti-Mouse CD3-FITC, anti-Mouse CD4-PE, anti-Mouse CD8-APC; IL-2, IL-6, IFN-γ kits, sIgA detection kit, etc.
[0139] 1.2 Animal grouping and drug administration
[0140] 78 ICR mice were randomly divided into 6 groups, including blank group (Control), model group (modle), and different doses of Stropharia capillaris polysaccharide groups (100mg / kg, 200mg / kg, 400mg / kg, 600mg / kg), with 12 mice in each group. The animals were allowed to drink water freely and the light was alternating between light and dark for 12h. The mice in the drug group were given drugs by gavage, and the control group was given an equal amount of normal saline by gavage every day for 14 consecutive days. The next experiment was carried out 24 hours after the last administration.
[0141] 1.3 Determination of mouse body weight and organ index
[0142] Two weeks after oral gavage, 24 hours after the last administration, 6 mice were taken from each group, weighed, blood was collected from the eyeballs, and then killed. The spleen and thymus were taken, the connective tissue was removed, the surface liquid was wiped dry, and the organ index was calculated by weighing.
[0143] Organ index = organ weight (g) / mouse body weight (kg)
[0144] 1.4 Histological observation of immune organs
[0145] After the thymus and spleen were weighed, the thymus and part of the spleen were fixed in formalin fixative, and HE sections were made to observe the histological changes of the thymus and spleen.
[0146] Effects of 1.5SRP on immune cytokine levels in mice
[0147] After blood was collected from the eyeballs of each group of mice, it was placed at room temperature for 30 minutes and centrifuged at 3000r / min for 10 minutes. The supernatant was taken for later use. The contents of IL-2, IL-6, and IFN-γ were detected according to the instructions of the ELISA kit.
[0148] 2 Experimental results
[0149] 2.1 Effects of SRP on body weight and organ indexes of mice
[0150] like Figure 8 , 9 As shown, SRP had no significant effect on the body weight, spleen index and thymus index of mice.
[0151] 2.2 Effects of SRP on the histology of immune organs
[0152] Fig.10 As shown, SRP did not affect the histomorphology of spleen and thymus.
[0153] Effects of SRP on the levels of immune cytokines and immunoglobulins in mice
[0154] like Fig.11 As shown, A is the content of IL-2 in serum, B is the content of IL-6 in serum, and C is the content of IFN-γ in serum, indicating that SRP can significantly increase the levels of IL-2, IL-6 and IFN-γ in mouse serum.
[0155] Example 5
[0156] This example is used to determine the regulatory effect of SRP on intestinal immunity and intestinal flora in immunosuppressed mice in Example 1:
[0157] 1 Experimental methods
[0158] 1.1 Drugs and materials
[0159] Stropharia capillaris polysaccharide, cyclophosphamide, anti-Mouse CD3-FITC, anti-Mouse CD4-PE, anti-Mouse CD8-APC, sIgA detection kit, etc.
[0160] 1.2 Experimental methods
[0161] 1.3 Animal grouping and drug administration
[0162] Same as 1.2 of Example 4.
[0163] 1.4 Intestinal histological observation
[0164] After the administration, 2 cm of the duodenum of each group of animals was taken and fixed with 4% paraformaldehyde, followed by embedding, slicing, staining and other steps, and finally the morphological changes were observed under a microscope.
[0165] 1.5 Determination of sIgA in mouse intestinal lavage fluid
[0166] After the administration, 10 cm of the ileum was taken and rinsed with 1 mL of PBS containing protease inhibitors. The rinse was repeated 7 times, and the rinse fluid was collected and centrifuged to obtain the supernatant for the determination of sIgA content.
[0167] 1.6 Activation of CD4+ and CD8+ T cells in mouse intestinal lymphocytes
[0168] After administration, the mesenteric lymph nodes of mice were collected (avoiding adipose tissue as much as possible), ground, sieved, centrifuged, and the middle layer of cloudy cells were carefully aspirated. The cells were washed twice with PBS, collected by centrifugation, resuspended in PBS, and stained with CD3, CD4, and CD8 antibodies. After staining, the cells were measured by flow cytometry.
[0169] 1.7 Studying intestinal microbiota by 16S rRNA gene sequencing
[0170] After the animals were killed, their feces were quickly collected, frozen in liquid nitrogen, and then stored in an ultra-low temperature refrigerator at -80°C. The samples were subjected to DNA extraction, 16S rDNA amplification, and high-throughput sequencing, and finally bioinformatics methods were used to clarify the regulatory effect of SRP on intestinal flora.
[0171] 2 Experimental results
[0172] 2.1 Effects of SRP on intestinal histology
[0173] like Fig.12 As shown, SRP can improve the intestinal morphology and structure of mice, making the intestinal villi longer, more numerous, and the number of crypt cells greater.
[0174] 2.2 Effect of SRP on intestinal sIgA secretion levels
[0175] like Fig.13 As shown, SRP can improve the secretion level of sIgA in the intestine.
[0176] 2.3 Effects of SRP on intestinal lymphocytes
[0177] like Fig.14 As shown, cyclophosphamide treatment significantly inhibited the activation of CD4+ T cells. Fig.15 As shown, SRP can increase the percentage of CD4 and CD8 lymphocytes.
[0178] 2.4 Effects of SRP on intestinal flora
[0179] like Fig.16 As shown in Figure 2, SRP can improve the uniformity and richness of the intestinal flora in immunosuppressed mice. Fig.17 As shown in Figure 2, SRP has a significant regulatory effect on β diversity. Fig.18 As shown in Figure 2, SRP reduced Firmicutes and increased Bacteroidetes at the phylum level, improving intestinal flora disturbance. Fig.19 As shown, SRP reduced the abundance of pathogenic bacteria Helicobacter and increased the abundance of probiotic bacteria Lactobacillus at the genus level.
[0180] It should be noted that the above examples are only used to illustrate the technical solution of the present invention rather than to limit it. Although the present invention is described in detail with reference to the given examples, those skilled in the art may modify or replace the technical solution of the present invention as needed without departing from the spirit and scope of the technical solution of the present invention.
Claims
1. Application of Stropharia rugosa polysaccharide in any one or more of the following: (a) Anti-oxidation or preparation of anti-oxidation products; (b) immunomodulation or preparation of immunomodulatory products; (c) Regulating intestinal flora or preparing products for regulating intestinal flora.
2. The use as claimed in claim 1, It is characterized in that The antioxidant is specifically manifested as scavenging free radicals DPPH and ABTS; The immunomodulation is immune enhancement; The intestinal flora regulation is to alleviate the intestinal flora disorder induced by immunosuppressants; specifically, it is manifested as: increasing the diversity of the intestinal flora of immunosuppressed mice, reducing the abundance of pathogenic bacteria Helicobacter and increasing the abundance of probiotics Lactobacillus; The Stropharia capillaris polysaccharide is extracted from Stropharia capillaris by water extraction and alcohol precipitation.
3. The use as claimed in claim 1, It is characterized in that The products mentioned include food and medicine; The food includes food for human consumption and food for non-human animal consumption (further including pet food, feed and feed additives); The drugs include drugs for human use and drugs for non-human animals (veterinary drugs); The non-human animals include vertebrates, further including fish, amphibians, reptiles, birds and mammals.
4. A method for preparing Stropharia rugosa polysaccharide, It is characterized in that The preparation method comprises: S1, extracting the stropharia with alcohol to remove pigments and fat-soluble small molecules, thereby obtaining stropharia residue; S2, drying the Stropharia officinalis residue obtained in step S1, adding water for hydrothermal extraction, filtering and collecting the supernatant; S3, subjecting the supernatant obtained in step S2 to alcohol precipitation, and collecting the precipitate; S4. After separation and purification of the precipitate in step S3, Stropharia capillaris polysaccharide is obtained.
5. The preparation method according to claim 4, It is characterized in that In the step S1, the specific method of the alcohol extraction includes: using ethanol (including 95% ethanol) for heating and reflux treatment 2-4 times.
6. The preparation method according to claim 4, It is characterized in that In step S2, the drying is natural drying in the shade, and the specific conditions for water heating extraction include: the extraction temperature is controlled at 90-100°C, the extraction time is 1-3 hours, and the number of extractions is 1-4 times; The mass ratio of the Stropharia officinalis medicinal residue to water is 1:5-15.
7. The preparation method according to claim 4, It is characterized in that In step S3, the alcohol precipitation treatment method includes: adding 75% ethanol to the supernatant to make the final concentration 60%, precipitating the polysaccharide with alcohol, and collecting the precipitate after standing; Furthermore, the ethanol is removed from the precipitate, and the precipitate is freeze-dried to obtain the crude polysaccharide of Stropharia rugosa.
8. The preparation method according to claim 4, It is characterized in that In step S4, the specific method of separation and purification includes adding Sevag reagent to remove protein, and column purification steps; Furthermore, the specific method of column purification includes chromatographic purification using DEAE-Sepharose FF ion exchange column chromatography and Chromdex 200PG gel filtration column; Furthermore, DEAE-Sepharose FF ion exchange column was used for elution according to different salt concentration solutions to obtain SRP-E1 (dH 2 O elution), SRP-E2 (0.2M NaCl elution), SRP-E3 (0.5M NaCl elution) and SRP-E4 (1.0M NaCl elution); the SRP-E1 component was purified using a Chromdex 200PG gel chromatography column; there was a highly symmetrical elution peak between 150-185min in the elution curve, and the purified SRP, i.e., Stropharia capillaris polysaccharide, was obtained after collection.
9. A product, It is characterized in that The product at least comprises the Stropharia capillaris polysaccharide prepared by the preparation method according to any one of claims 4 to 8; The products include food and medicine.
10. The product according to claim 9, It is characterized in that The food may include food for human consumption and food for non-human animal consumption (including pet food, feed and feed additives); The drugs include drugs for human use and drugs for non-human animals (veterinary drugs); The non-human animals include vertebrates, further including fish, amphibians, reptiles, birds and mammals; The product has any one or more of the following effects: (a) Antioxidant; (b) immune regulation; (c) Regulation of intestinal flora.
